HEADER HYDROLASE 03-JUN-05 1ZVX TITLE CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A PHOSPHONATE TITLE 2 INHIBITOR (R-ENANTIOMER) COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEUTROPHIL COLLAGENASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN OF NEUTROPHIL COLLAGENASE (RESIDUES:80- COMPND 5 242); COMPND 6 SYNONYM: MATRIX METALLOPROTEINASE-8, MMP-8, PMNL COLLAGENASE, PMNL- COMPND 7 CL; COMPND 8 EC: 3.4.24.34; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MMP8, CLG1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PSVB30 KEYWDS STEREOSELECTIVE INHIBITION, PHOSPHONIC INHIBITORS, HYDROLASE, KEYWDS 2 SULFONAMIDE JUNCTION EXPDTA X-RAY DIFFRACTION AUTHOR G.POCHETTI,E.GAVUZZO,C.CAMPESTRE,M.AGAMENNONE,P.TORTORELLA, AUTHOR 2 V.CONSALVI,C.GALLINA,O.HILLER,H.TSCHESCHE,P.A.TUCKER,F.MAZZA REVDAT 5 23-AUG-23 1ZVX 1 REMARK LINK REVDAT 4 24-JAN-18 1ZVX 1 JRNL REVDAT 3 11-OCT-17 1ZVX 1 REMARK REVDAT 2 24-FEB-09 1ZVX 1 VERSN REVDAT 1 16-MAY-06 1ZVX 0 JRNL AUTH G.POCHETTI,E.GAVUZZO,C.CAMPESTRE,M.AGAMENNONE,P.TORTORELLA, JRNL AUTH 2 V.CONSALVI,C.GALLINA,O.HILLER,H.TSCHESCHE,P.A.TUCKER,F.MAZZA JRNL TITL STRUCTURAL INSIGHT INTO THE STEREOSELECTIVE INHIBITION OF JRNL TITL 2 MMP-8 BY ENANTIOMERIC SULFONAMIDE PHOSPHONATES. JRNL REF J.MED.CHEM. V. 49 923 2006 JRNL REFN ISSN 0022-2623 JRNL PMID 16451058 JRNL DOI 10.1021/JM050787+ REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.G.PAVLOVSKY,M.G.WILLIAMS,Q.Z.YE,D.F.ORTWINE, REMARK 1 AUTH 2 C.F.PURCHASE II,A.D.WHITE,V.DHANARAJ,B.D.ROTH,L.L.JOHNSON, REMARK 1 AUTH 3 D.HUPE,C.HUMBLET,T.L.BLUNDELL REMARK 1 TITL X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN REMARK 1 TITL 2 COMPLEXED WITH NONPEPTIDE INHIBITORS: IMPLICATIONS FOR REMARK 1 TITL 3 INHIBITOR SELECTIVITY REMARK 1 REF PROTEIN SCI. V. 8 1455 1999 REMARK 1 REFN ISSN 0961-8368 REMARK 1 PMID 10422833 REMARK 1 REFERENCE 2 REMARK 1 AUTH E.GAVUZZO,G.POCHETTI,F.MAZZA,C.GALLINA,B.GORINI,S.D'ALESSIO, REMARK 1 AUTH 2 M.PIEPER,H.TSCHESCHE,P.A.TUCKER REMARK 1 TITL TWO CRYSTAL STRUCTURES OF HUMAN NEUTROPHIL COLLAGENASE, ONE REMARK 1 TITL 2 COMPLEXED WITH A PRIMED- AND THE OTHER WITH AN UNPRIMED-SIDE REMARK 1 TITL 3 INHIBITOR: IMPLICATIONS FOR DRUG DESIGN REMARK 1 REF J.MED.CHEM. V. 43 3377 2000 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 10978185 REMARK 1 DOI 10.1021/JM9909589 REMARK 1 REFERENCE 3 REMARK 1 AUTH F.GRAMS,P.REINEMER,J.C.POWERS,T.KLEINE,M.PIEPER,H.TSCHESCHE, REMARK 1 AUTH 2 R.HUBER,W.BODE REMARK 1 TITL X-RAY STRUCTURESOF HUMAN NEUTROPHIL COLLAGENASE COMPLEXED REMARK 1 TITL 2 WITH PEPTIDE HYDROXAMATE AND PEPTIDE THIOL INHIBITORS. REMARK 1 TITL 3 IMPLICATIONS FOR SUBSTRATE BINDING AND RATIONAL DRUG DESIGN REMARK 1 REF EUR.J.BIOCHEM. V. 228 830 1995 REMARK 1 REFN ISSN 0014-2956 REMARK 1 PMID 7737183 REMARK 1 DOI 10.1111/J.1432-1033.1995.TB20329.X REMARK 2 REMARK 2 RESOLUTION. 1.87 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.87 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 9924 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1014 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1282 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 144 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1ZVX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-JUN-05. REMARK 100 THE DEPOSITION ID IS D_1000033184. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JAN-04 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X13 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8042 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10210 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.870 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.87 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.94 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.30400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1I76 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 24.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG6000, MES/NAOH, NACL, CACL2, ZNCL2, REMARK 280 NAPHOSPHATE, PH 6.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 291.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 16.35300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 34.20650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.37700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 34.20650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 16.35300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.37700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 82 143.09 -28.66 REMARK 500 ARG A 145 -126.51 41.88 REMARK 500 HIS A 147 35.69 -143.11 REMARK 500 ASP A 149 18.12 -144.03 REMARK 500 ASN A 150 -35.41 71.86 REMARK 500 ASN A 157 -170.81 64.26 REMARK 500 ALA A 161 -174.88 -176.40 REMARK 500 ALA A 220 109.34 -165.76 REMARK 500 SER A 225 -86.81 -63.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 HOH A 1115 REMARK 615 HOH A 1121 REMARK 615 HOH A 1132 REMARK 615 HOH A 1140 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 996 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 137 O REMARK 620 2 GLY A 169 O 162.3 REMARK 620 3 GLY A 171 O 92.3 96.0 REMARK 620 4 ASP A 173 OD1 91.1 102.5 101.2 REMARK 620 5 HOH A1060 O 91.2 75.6 158.8 99.7 REMARK 620 6 HOH A1101 O 83.0 83.3 78.9 174.1 80.7 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 998 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 147 NE2 REMARK 620 2 ASP A 149 OD2 110.9 REMARK 620 3 HIS A 162 NE2 115.3 113.6 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 997 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 154 OD1 REMARK 620 2 GLY A 155 O 89.3 REMARK 620 3 ASN A 157 O 85.0 80.2 REMARK 620 4 ILE A 159 O 86.7 175.3 101.9 REMARK 620 5 ASP A 177 OD2 91.0 89.8 169.2 87.8 REMARK 620 6 GLU A 180 OE2 170.3 96.3 88.2 88.0 96.9 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 999 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 197 NE2 REMARK 620 2 HIS A 201 NE2 110.3 REMARK 620 3 HIS A 207 NE2 115.0 102.5 REMARK 620 4 FIN A 994 O6 109.6 120.6 98.4 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 996 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 997 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 998 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 999 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FIN A 994 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ZS0 RELATED DB: PDB DBREF 1ZVX A 80 242 UNP P22894 MMP8_HUMAN 100 262 SEQRES 1 A 163 MET LEU THR PRO GLY ASN PRO LYS TRP GLU ARG THR ASN SEQRES 2 A 163 LEU THR TYR ARG ILE ARG ASN TYR THR PRO GLN LEU SER SEQRES 3 A 163 GLU ALA GLU VAL GLU ARG ALA ILE LYS ASP ALA PHE GLU SEQRES 4 A 163 LEU TRP SER VAL ALA SER PRO LEU ILE PHE THR ARG ILE SEQRES 5 A 163 SER GLN GLY GLU ALA ASP ILE ASN ILE ALA PHE TYR GLN SEQRES 6 A 163 ARG ASP HIS GLY ASP ASN SER PRO PHE ASP GLY PRO ASN SEQRES 7 A 163 GLY ILE LEU ALA HIS ALA PHE GLN PRO GLY GLN GLY ILE SEQRES 8 A 163 GLY GLY ASP ALA HIS PHE ASP ALA GLU GLU THR TRP THR SEQRES 9 A 163 ASN THR SER ALA ASN TYR ASN LEU PHE LEU VAL ALA ALA SEQRES 10 A 163 HIS GLU PHE GLY HIS SER LEU GLY LEU ALA HIS SER SER SEQRES 11 A 163 ASP PRO GLY ALA LEU MET TYR PRO ASN TYR ALA PHE ARG SEQRES 12 A 163 GLU THR SER ASN TYR SER LEU PRO GLN ASP ASP ILE ASP SEQRES 13 A 163 GLY ILE GLN ALA ILE TYR GLY HET CA A 996 1 HET CA A 997 1 HET ZN A 998 1 HET ZN A 999 1 HET FIN A 994 26 HETNAM CA CALCIUM ION HETNAM ZN ZINC ION HETNAM FIN (1R)-1-{[(4'-METHOXY-1,1'-BIPHENYL-4-YL) HETNAM 2 FIN SULFONYL]AMINO}-2-METHYLPROPYLPHOSPHONIC ACID FORMUL 2 CA 2(CA 2+) FORMUL 4 ZN 2(ZN 2+) FORMUL 6 FIN C17 H22 N O6 P S FORMUL 7 HOH *144(H2 O) HELIX 1 1 SER A 105 VAL A 122 1 18 HELIX 2 2 ASN A 190 LEU A 203 1 14 HELIX 3 3 PRO A 230 GLY A 242 1 13 SHEET 1 A 5 ILE A 127 ARG A 130 0 SHEET 2 A 5 ASN A 92 ILE A 97 1 N LEU A 93 O THR A 129 SHEET 3 A 5 ILE A 138 TYR A 143 1 O ILE A 140 N ARG A 96 SHEET 4 A 5 ALA A 174 ASP A 177 1 O PHE A 176 N ALA A 141 SHEET 5 A 5 ALA A 161 ALA A 163 -1 N HIS A 162 O HIS A 175 LINK O ASP A 137 CA CA A 996 1555 1555 2.45 LINK NE2 HIS A 147 ZN ZN A 998 1555 1555 2.05 LINK OD2 ASP A 149 ZN ZN A 998 1555 1555 2.13 LINK OD1 ASP A 154 CA CA A 997 1555 1555 2.54 LINK O GLY A 155 CA CA A 997 1555 1555 2.40 LINK O ASN A 157 CA CA A 997 1555 1555 2.50 LINK O ILE A 159 CA CA A 997 1555 1555 2.44 LINK NE2 HIS A 162 ZN ZN A 998 1555 1555 2.10 LINK O GLY A 169 CA CA A 996 1555 1555 2.52 LINK O GLY A 171 CA CA A 996 1555 1555 2.54 LINK OD1 ASP A 173 CA CA A 996 1555 1555 2.53 LINK OD2 ASP A 177 CA CA A 997 1555 1555 2.51 LINK OE2 GLU A 180 CA CA A 997 1555 1555 2.44 LINK NE2 HIS A 197 ZN ZN A 999 1555 1555 2.13 LINK NE2 HIS A 201 ZN ZN A 999 1555 1555 2.09 LINK NE2 HIS A 207 ZN ZN A 999 1555 1555 2.15 LINK O6 FIN A 994 ZN ZN A 999 1555 1555 1.98 LINK CA CA A 996 O HOH A1060 1555 1555 2.61 LINK CA CA A 996 O HOH A1101 1555 1555 2.65 CISPEP 1 ASN A 188 TYR A 189 0 0.07 SITE 1 AC1 6 ASP A 137 GLY A 169 GLY A 171 ASP A 173 SITE 2 AC1 6 HOH A1060 HOH A1101 SITE 1 AC2 6 ASP A 154 GLY A 155 ASN A 157 ILE A 159 SITE 2 AC2 6 ASP A 177 GLU A 180 SITE 1 AC3 4 HIS A 147 ASP A 149 HIS A 162 HIS A 175 SITE 1 AC4 4 HIS A 197 HIS A 201 HIS A 207 FIN A 994 SITE 1 AC5 19 ILE A 159 LEU A 160 ALA A 161 HIS A 162 SITE 2 AC5 19 LEU A 193 HIS A 197 GLU A 198 HIS A 201 SITE 3 AC5 19 HIS A 207 LEU A 214 TYR A 216 PRO A 217 SITE 4 AC5 19 ASN A 218 TYR A 219 ZN A 999 HOH A1008 SITE 5 AC5 19 HOH A1026 HOH A1053 HOH A1114 CRYST1 32.706 54.754 68.413 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.030575 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018264 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014617 0.00000